StockData
OrthoPediatrics Corp logo

OrthoPediatrics Corp (KIDS) stock

KIDSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/308% below fair value
$31.65+0.24 (+0.76%)

Close on Nov 18, 2026Market cap $826.40MP/E –Yield –

OrthoPediatrics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

OrthoPediatrics's total debt was $101.13M at Sep 30, 2026. For fiscal 2025 it was $101.68M, up 37.7% from the year before. The highest annual figure on record is $101.68M in fiscal 2025.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$101.68M+37.7%
FY2024Dec 31, 2024$73.85M+634.1%
FY2023Dec 31, 2023$10.06M+1009.2%
FY2022Dec 31, 2022$907.00K-13.1%
FY2021Dec 31, 2021$1.04M-11.1%
FY2020Dec 31, 2020$1.18M-95.5%
FY2019Dec 31, 2019$26.19M+23.1%
FY2018Dec 31, 2018$21.27M-16.4%
FY2017Dec 31, 2017$25.45M+45.1%
FY2016Dec 31, 2016$17.54M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$101.13M+0.4%
Q2 FY2026Jun 30, 2026$101.99M+4.2%
Q1 FY2026Mar 31, 2026$102.61M+38.8%
Q4 FY2025Dec 31, 2025$101.68M+37.7%
Q3 FY2025Sep 30, 2025$100.70M+37.7%
Q2 FY2025Jun 30, 2025$97.84M+884.5%
Q1 FY2025Mar 31, 2025$73.92M+617.4%
Q4 FY2024Dec 31, 2024$73.85M+634.1%
Q3 FY2024Sep 30, 2024$73.14M+7963.7%
Q2 FY2024Jun 30, 2024$9.94M+851.9%
Q1 FY2024Mar 31, 2024$10.31M+801.6%
Q4 FY2023Dec 31, 2023$10.06M+756.2%
Q4 FY2022Dec 31, 2022$907.00K-24.9%
Q4 FY2021Dec 31, 2021$1.04M-95.1%
Q1 FY2021Mar 31, 2021$1.14M-94.6%
Q4 FY2020Dec 31, 2020$1.18M-95.5%
Q3 FY2020Sep 30, 2020$1.21M-98.5%
Q2 FY2020Jun 30, 2020$21.15M-74.0%
Q1 FY2020Mar 31, 2020$21.17M-0.4%
Q4 FY2019Dec 31, 2019$26.19M+23.1%
Q3 FY2019Sep 30, 2019$81.21M+219.8%
Q2 FY2019Jun 30, 2019$81.23M+219.7%
Q1 FY2019Mar 31, 2019$21.25M-16.4%
Q4 FY2018Dec 31, 2018$21.27M-16.4%
Q3 FY2018Sep 30, 2018$25.39M-8.0%
Q2 FY2018Jun 30, 2018$25.41M+44.9%
Q1 FY2018Mar 31, 2018$25.43M–
Q4 FY2017Dec 31, 2017$25.45M–
Q3 FY2017Sep 30, 2017$27.60M–
Q4 FY2016Dec 31, 2016$17.54M–

More OrthoPediatrics figures

See a number that looks wrong?